Oryzon Genomics S.A.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Oryzon Genomics S.A.'s past years’ income statements indicate that its last revenue has decreased compared to the previous period by 7% to $15,667,489. The net income raised on -$3,701,637 and profit margin reached -24%. Total operating expenses were $20,420,741.
Profit Margin
| 2014 | 18.80M | 8.04M | 42.81% |
|---|---|---|---|
| 2015 | 7.80M | -1.07M | -13.81% |
| 2016 | 5.00M | -5.44M | -108.76% |
| 2017 | 5.17M | -6.23M | -120.38% |
| 2018 | 6.78M | -1.17M | -17.36% |
| 2019 | 11.52M | -4.13M | -35.85% |
| 2020 | 11.63M | -4.15M | -35.71% |
| 2021 | 12.08M | -5.33M | -44.15% |
| 2022 | 16.80M | -4.53M | -26.95% |
| 2023 | 15.66M | -3.70M | -23.63% |
0RDB.L Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 15.66M | 16.80M | 12.08M | 11.63M | 11.52M | 6.78M | 5.17M | 5.00M | 7.80M | 18.80M |
Cost of revenue | 269.04K | 496.98K | 849.05K | 642.99K | 482.5K | 292.66K | 326.31K | 370.97K | 388.29K | 412.76K |
Gross profit | 15.39M | 16.31M | 11.23M | 10.98M | 11.04M | 6.48M | 4.85M | 4.63M | 7.41M | 18.39M |
Operating exp. | ||||||||||
Research and development | 6.88M | 7.09M | 8.37M | 5.96M | 5.40M | 4.10M | 7.60M | 7.36M | 6.83M | 6.95M |
Selling and marketing | -265.94K | 0 | 0 | 0 | 0 | 3.08M | 0 | 2.57M | 2.06M | 0 |
Total operating expenses | 20.42M | 22.14M | 18.89M | 16.25M | 15.33M | -9.39M | 10.23M | -9.20M | 7.76M | 9.47M |
Operating income | -5.02M | -5.88M | -7.98M | -5.24M | -4.30M | -3.23M | -5.67M | -4.94M | -783.13K | 11.94M |
Other income (expenses), net | -1.71M | -1.13M | -189.75K | -596.33K | -832.31K | -475.68K | -1.11M | -529.87K | -784.16K | 744.49K |
Income before tax | -6.73M | -7.02M | -8.17M | -5.83M | -5.13M | -3.71M | -6.30M | -5.47M | -1.03M | 8.15M |
Income tax expense | 3.03M | 2.48M | 2.83M | 1.68M | 1.00M | 2.53M | 66.03K | 31.57K | 40.13K | 107.09K |
Net income | -3.70M | -4.53M | -5.33M | -4.15M | -4.13M | -1.17M | -6.23M | -5.44M | -1.07M | 8.04M |
Earnings per share | ||||||||||
Basic EPS | -0.06 | -0.08 | -0.1 | -0.07 | -0.09 | -0.03 | -0.19 | -0.2 | -0.03 | 0.3 |
Diluted EPS | -0.06 | -0.08 | -0.1 | -0.07 | -0.09 | -0.03 | -0.19 | -0.2 | -0.03 | 0.3 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |